Our Story

“Welcome to APS Pharma., a tenacious innovation driven company specializing in simplifying preclinical and early clinical drug development. Established in 2021 in the suburban Toronto metropolitan area by industry professionals with a proven track record of successful introduction of new molecular entities into pre-clinical and clinical lifecycle phases. Our founders envisioned a company focused on customized synthetic and process chemistry solutions and Good Manufacturing Practices (GMP) manufacturing.”

Propelled by Success

Propelled by our past successes and growth, and with a desire to focus on custom synthesis requests and GMP manufacturing, company founders expanded our service offering with the decision, in 2021, to form a new company, Acanthus Pharma Services Inc. As a CDMO, we are focused on preclinical and early clinical drug development. Our mission is to provide tailored products and services that match your needs. Our strategy is to partner with and help you accelerate your internal programs into the clinical arena or towards your next clinical milestone.

Fortitude + Confidence x Acceleration = Success

Our Purpose

Mission

Our mission is to empower biotechnology and pharmaceutical companies with expert process chemistry services, delivering tailored solutions that drive the discovery and production of life-saving therapeutics.

Vision

To be a trusted partner to biotechnology and pharmaceutical industries to support the advancement of global healthcare through accelerated therapy development.

Synthesizing Success One Molecule at a Time

Why Choose Us?

The key word that we base our activities on is "custom". We consider it our responsibility as a company to commit to your requirements and support the bigger picture you have envisioned for your molecules. We do not force you to conform to our standard product offering, instead we conform to your requests.

We are a boutique firm with no tedious layers of democracy. We are agile & hold quality as one of the key components of our operations hence we are always ready to deliver value to our clients.

To be a trusted partner to biotechnology and pharmaceutical industries to support the advancement of global healthcare through accelerated therapy development.

Clinical Stage of Interest

Where we fit in the development cycle.

Working Together. Smarter and Faster.

Our Team

Stefan Wodzinski, Ph.D.

Chief Executive Officer

Ph.D. in Organic Chemistry, University of Toronto
24 years industrial experience at Teva, Taro, and Apotex Pharmachem
Broad expertise in organic chemistry, process development, scale-up, process optimization, development of regulatory framework, troubleshooting, alternate route development
Business and finance

Jolanta Wodzinska, Ph.D.

Chief Scientific and Innovation Officer

Ph.D. in Organic Chemistry, University of Toronto
24 years industrial experience at MIT, Hemosol, ApoPharma
Broad expertise in nonclinical drug discovery
Business development, sales, and finance